Navigation Links
Indiana State Medical Association and AARP Urge Reconsideration of Bill to Protect Seniors' Access to Doctors and Improve Medicare
Date:7/2/2008

ving care for our nation's seniors, disabled individuals and military families hanging in the balance," Dr. Marhenke said. "We call on the senator to reconsider his vote and return to Washington to do what's right - vote to ensure patient access to care and give health care security to America's elderly."

In addition to preventing a 10.6 percent cut in payments to doctors, the Medicare bill would have:

-- Helped keep premiums fair

-- Strengthened protections for lower income beneficiaries

-- Improved Medicare's coverage of preventive services

-- Made Medicare more efficient through electronic prescribing.

The Senate is currently scheduled to reconsider H.R. 6331 immediately following the July 4th recess. "We're urging seniors and their physicians to contact Sen. Lugar on this important issue that will have a huge impact on Medicare patients' access to doctors in the future," said Dr. Marhenke.

Throughout the debate on this Medicare legislation, AARP, the American Medical Association and the ISMA have engaged their members in a fight to keep Medicare fair and protect access to doctors. Hundreds of thousands of AARP supporters, including 19,000 Hoosiers, called and e-mailed Congress, signed petitions, wrote letters to their local papers and participated in "Keep Medicare Fair" events around the country in the last several weeks.

More than 41,000 patients and physicians called Congress in June, using a hotline provide by the AMA. During the July 4th recess, the AMA is airing new radio and television ads that urge opponents of H.R. 6331 to put patients' access to care before insurance profits by voting for the bill as soon as they return to Washington next week.

Representing approximately 8,400 of the state's physicians, the ISMA has worked for 158 years to promote sound health care policy in the public, private and governmental sectors and to support continuing medical education for the state's doctors. '/>"/>

SOURCE AARP Indiana
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
2. EPA: Nine Indiana Counties Now Meet the Health Standard for Smog
3. Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign
4. Indiana Legislature Should Protect All Workers from Secondhand Smoke
5. Tobacco-Free Kids Indiana Action Fund Launches Campaign in Support of Angela Mansfield and Scott Keller for Indianapolis City-County Council
6. Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. EPA Awards Grant to American Lung Association of Indiana for Community Environmental Health Initiative
8. Medco to Build Worlds Largest, Most Advanced Automated Pharmacy in Central Indiana
9. Anthem Blue Cross and Blue Shield in Indiana Releases State Health Index
10. Brown Mackie College - Indianapolis Announces New Degree Program in Occupational Therapy
11. HHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 1U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 4U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 5West to Present at Two Upcoming Investor Conferences 56960 1West to Present at Two Upcoming Investor Conferences 56960 2Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 1Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 2